Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

In vitro studies on anthracycline haloderivatives.

T Facchinetti, C Geroni, A Fumagalli

    Drugs Under Experimental and Clinical Research
    |January 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Precision oncology in biliary tract cancer: the emerging role of liquid biopsy.

    ESMO open·2025
    Same author

    Quantum circuits with many photons on a programmable nanophotonic chip.

    Nature·2021
    Same author

    Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study.

    Breast (Edinburgh, Scotland)·2017
    Same author

    Effects of consumption of whole grain foods rich in lignans in healthy postmenopausal women with moderate serum cholesterol: a pilot study.

    International journal of food sciences and nutrition·2014
    Same author

    Colorectal cancer screening in LHU4 Chiavarese, Italy: ethical, methodological and outcome evaluations at the end of the first round.

    Journal of preventive medicine and hygiene·2012
    Same author

    Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.

    Journal of internal medicine·2004
    Same journal

    A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.

    Drugs under experimental and clinical research·2006
    Same journal

    Psychiatric factors in patients with sensitive skin.

    Drugs under experimental and clinical research·2006
    Same journal

    Objective biophysical findings in patients with sensitive skin.

    Drugs under experimental and clinical research·2006
    Same journal

    Is itraconazole the treatment of choice in Microsporum canis tinea capitis?

    Drugs under experimental and clinical research·2006
    Same journal

    Improvement of otitis media with effusion after treatment of asthma with leukotriene antagonists in children with co-existing disease.

    Drugs under experimental and clinical research·2006
    Same journal

    Twice-daily dosing of loracarbef 15 mg/kg versus 30 mg/kg in the treatment of children with acute sinusitis.

    Drugs under experimental and clinical research·2006
    See all related articles

    New halogenated anthracycline derivatives show enhanced cytotoxicity against cancer cells, including doxorubicin-resistant lines. These compounds accumulate effectively within cells, suggesting potential for improved cancer therapies.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Cancer Biology

    Background:

    • Anthracyclines like doxorubicin (DX) and daunorubicin (DNR) are vital chemotherapeutics.
    • Drug resistance, particularly to doxorubicin, limits treatment efficacy.
    • Novel anthracycline derivatives are needed to overcome resistance mechanisms.

    Purpose of the Study:

    • To synthesize and evaluate novel 4'-haloanthracycline derivatives.
    • To compare their cytotoxicity and cellular accumulation against parent drugs.
    • To assess their potential against sensitive and doxorubicin-resistant cancer cell lines.

    Main Methods:

    • Synthesis of 4'-haloanthracycline derivatives.
    • Cytotoxicity assays on HeLa, P388, and P388/DX cell lines.

    Related Experiment Videos

  • Cellular kinetic studies to measure drug accumulation.

    • Main Results:

    • 4'-Haloderivatives of doxorubicin exhibited greater cytotoxicity than doxorubicin across tested cell lines.
    • Doxorubicin haloderivatives showed increased intracellular accumulation compared to doxorubicin.
    • Daunorubicin haloderivatives showed similar accumulation in sensitive cells but higher accumulation in resistant cells.

    Conclusions:

    • 4'-Haloanthracycline derivatives possess promising cytotoxic activity, especially against anthracycline-resistant cell lines.
    • Enhanced cytotoxicity may be linked to increased intracellular drug accumulation and other factors.
    • These novel compounds represent a potential strategy to overcome doxorubicin resistance in cancer treatment.